Quest Diagnostics Incorporated (NYSE:DGX) Q1 2024 Earnings Call Transcript
Quest Diagnostics Incorporated beats earnings expectations. Reported EPS is $2.04, expectations were $1.86.
Source: insidermonkey.com
📰 Early Experience Program News
Early Experience Program News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Early Experience Program. Real-time updates on events, politics, business and more.
Early Experience Using Intravesical Gene Therapy for NMIBC: Perspectives from Urinary Oncologists
For more than 30 years, there has been little treatment advancement for NMIBC patients. Fortunately, a new development in the treatment of NMIBC has been approved by the FDA and is now available.
United States Banner Gateway Medical Center Chinedu Mmeje Joseph Mashni Jr Urol Onc American Cancer Society
Source: pharmacytimes.com
Early Experience Program Doses First Patient With Intravesical Gene Therapy at Urology Practice
Access to gene therapies can pose challenges for patients.
United States Philippe Nabbout Wichita Urology Group Ferring Pharmaceuticals Early Experience Program Early Experience
Source: pharmacytimes.com